BIOC Still Failing To Fill

COMMENTARY
BIOC is one of those penny stocks that have individual, good days. But when it comes to putting together a string of bullish action, it has yet to reach that milestone. Furthermore, though volume is good, the company still needs to execute further in my opinion. Either way. It's a good day today but would like to put this on a 30 day time clock and see where things are, at that time.

QUOTE
"On Tuesday (1-14) the company reported that its Target Selector™ assays are now available to doctors. The goal is for these doctors to use the Target Selector™ to evaluate cerebrospinal fluid of patients and check for the presence of circulating tumor cells for patients with breast or lung cancer suspected of brain or nervous system metastases.According to the company, the presence of tumor cells in the central nervous system might indicate brain metastases that can happen when cancer has spread to these locations. Thanks to this update, shares of Biocept rallied."

QUOTE Source: Top Penny Stocks To Watch Right Now; 1 Up Over 100% Since November
BIOCbiotechdaytradingpennystocksrobinhoodrobinhoodsignalstradingsignalsTrend Analysistrending

Also on:

Disclaimer